| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/08/1997 | US5618671 Method and system for molecular-biological diagnostics |
| 04/08/1997 | US5618666 Nucleic acids derived from Salmonella typhi and detection of Salmonella using thereof |
| 04/08/1997 | US5618542 Vaccines comprising antigenic polypeptides of Taenia ovis |
| 04/08/1997 | US5618536 Chimeric papillomavirus-like particles |
| 04/08/1997 | US5618534 Isolated antigen endo glyx-1 |
| 04/08/1997 | US5618532 Dirofilaria immitis Gp29 proteins and uses thereof |
| 04/08/1997 | CA2090355C Method of gene transfer using galactosylated histones |
| 04/03/1997 | WO1997012061A1 Method for characterizing nucleic acid molecules |
| 04/03/1997 | WO1997012060A1 ARF-p19, A NOVEL REGULATOR OF THE MAMMALIAN CELL CYCLE |
| 04/03/1997 | WO1997012059A1 Brown stem rot resistance in soybeans |
| 04/03/1997 | WO1997012057A1 Chemotherapeutic agents for mycobacterium |
| 04/03/1997 | WO1997012052A1 Transduction of hematopoietic cells by viral vector and a cationic lipid |
| 04/03/1997 | WO1997012051A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 04/03/1997 | WO1997012050A1 Method for transferring genes to the heart using aav vectors |
| 04/03/1997 | WO1997012049A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 04/03/1997 | WO1997012048A1 Recombinant viruses incorporating a protease cleavable protein |
| 04/03/1997 | WO1997012047A1 Plant stearoyl-acp thioesterase sequences and methods to increase stearate content in plant seed oils |
| 04/03/1997 | WO1997012046A1 Improved integration of exogenous dna delivered to eukaryotic cells |
| 04/03/1997 | WO1997012045A1 Method of making a protease deficient host |
| 04/03/1997 | WO1997012044A2 Pichia secretory leader for protein expression |
| 04/03/1997 | WO1997012043A2 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 04/03/1997 | WO1997012042A2 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | WO1997012041A1 SHORT FORMS OF CHEMOKINE β-8 |
| 04/03/1997 | WO1997012040A1 GENE THERAPY WITH MODIFIED p65 PROTEINS |
| 04/03/1997 | WO1997012039A2 Sh2-containing inositol-phosphatase |
| 04/03/1997 | WO1997012037A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 04/03/1997 | WO1997012036A2 Bone stimulating factor |
| 04/03/1997 | WO1997012035A2 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 04/03/1997 | WO1997012034A1 A modified glutamic acid decarboxylase (gad) |
| 04/03/1997 | WO1997012033A1 Recombinant hepatitis c virus rna replicase |
| 04/03/1997 | WO1997012032A1 Production of infectious respiratory syncytial virus from cloned nucleotide sequences |
| 04/03/1997 | WO1997012030A1 Apparatus and methods for active programmable matrix devices |
| 04/03/1997 | WO1997011972A1 Chimeric dna-binding/dna methyltransferase nucleic acid and polypeptide and uses thereof |
| 04/03/1997 | WO1997011970A1 Cytostatin ii |
| 04/03/1997 | WO1997011969A1 Type cc chemokine-like protein |
| 04/03/1997 | WO1997011968A2 A gene associated with liver neoplastic disease |
| 04/03/1997 | WO1997011965A1 Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 04/03/1997 | WO1997011964A1 Truncated glial cell line-derived neurotrophic factor |
| 04/03/1997 | WO1997011963A1 ANTI-GALα(1,3)GAL ANTIBODY BINDING PEPTIDES |
| 04/03/1997 | WO1997011956A1 IDENTIFICATION OF sel-12 AND USES THEREOF |
| 04/03/1997 | WO1997011720A1 Methods for treating cancers and restenosis with p21 |
| 04/03/1997 | WO1997011716A1 Manipulation of non-terminally differentiated cells using the notch pathway |
| 04/03/1997 | WO1997011715A1 Mimicking peptides in cancer therapy |
| 04/03/1997 | WO1997011714A1 Chemokine inhibitor |
| 04/03/1997 | WO1997011713A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
| 04/03/1997 | WO1997011690A2 Inhibitors of regulatory pathways |
| 04/03/1997 | WO1997011604A1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/03/1997 | WO1997011598A1 Method for treating hepatitis virus infection |
| 04/03/1997 | WO1997011597A1 Method for preparing transgenic animal |
| 04/03/1997 | WO1997005771A3 Lysosomal proteins produced in the milk of transgenic animals |
| 04/03/1997 | WO1997004101A3 Enzyme suitable for oxidising cyclitols and their derivatives |
| 04/03/1997 | WO1997003198A3 Nucleotide and amino acid sequence and uses thereof |
| 04/03/1997 | WO1997003192A3 Chromosome 1 gene and gene products related to alzheimer's disease |
| 04/03/1997 | WO1997001634A3 Polypeptide for repairing genetic information, nucleotidic sequence which codes for it and process for the preparation thereof (guanine thymine binding protein - gtbp) |
| 04/03/1997 | WO1996040948A3 Resistance to viruses and viroids in transgenic plant and animal hosts expressing dsrna-binding protein |
| 04/03/1997 | WO1996039516A3 Targets for breast cancer diagnosis and treatment |
| 04/03/1997 | WO1996038473A3 Antimicrobial cationic peptides |
| 04/03/1997 | CA2233694A1 Method for preparing transgenic animal |
| 04/03/1997 | CA2233367A1 Short forms of chemokine .beta.-8 |
| 04/03/1997 | CA2233361A1 Cytostatin ii |
| 04/03/1997 | CA2233309A1 Recombinant hepatitis c virus rna replicase |
| 04/03/1997 | CA2233297A1 Identification of sel-12 and uses thereof |
| 04/03/1997 | CA2233238A1 Apparatus and methods for active programmable matrix devices |
| 04/03/1997 | CA2233167A1 Method for transferring genes to the heart using aav vectors |
| 04/03/1997 | CA2233060A1 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 04/03/1997 | CA2233040A1 Transgenic animals for xenotransplantation with reduced antibody-mediated rejection |
| 04/03/1997 | CA2233031A1 Gene therapy with modified p65 proteins |
| 04/03/1997 | CA2232937A1 Porcine cell interaction proteins |
| 04/03/1997 | CA2232706A1 Chemokine inhibitor |
| 04/03/1997 | CA2232669A1 Recombinant viruses incorporating a protease cleavable protein |
| 04/03/1997 | CA2231735A1 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 04/03/1997 | CA2231064A1 Pharmaceutical composition useful for nucleic acid transfection, and use thereof |
| 04/03/1997 | CA2230933A1 Lantibiotic mutants and chimeras of enhanced stability and activity |
| 04/03/1997 | CA2230128A1 A modified glutamic acid decarboxylase (gad) |
| 04/03/1997 | CA2205657A1 Plant stearoyl-acp thioesterase sequences and methods to increase stearate content in plant seed oils |
| 04/02/1997 | EP0765939A2 Family of xanthan-based polysaccharide polymers including non-acetylated and/or non-pyruvylated gum |
| 04/02/1997 | EP0765937A1 Method of producing fusion proteins |
| 04/02/1997 | EP0765936A1 Cloning of mite allergens |
| 04/02/1997 | EP0765478A1 Positive and positive/negative cell selection mediated by peptide release |
| 04/02/1997 | EP0765403A1 System to detect protein-rna interactions |
| 04/02/1997 | EP0765398A1 Population of cells enriched for myeloid and/or lymphoid progenitors and methods of making and using |
| 04/02/1997 | EP0765397A1 Method for introduction of genetic material into microorganisms and transformants obtained therewith |
| 04/02/1997 | EP0765396A1 Locus control subregions for integration-site independent transgene expression |
| 04/02/1997 | EP0765395A1 N-terminally extended proteins expressed in yeast |
| 04/02/1997 | EP0765394A1 Purified myceliophthora laccases and nucleic acids encoding same |
| 04/02/1997 | EP0765393A1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator |
| 04/02/1997 | EP0765392A1 Interleukin-5 specific recombinant antibodies |
| 04/02/1997 | EP0765391A1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 04/02/1997 | EP0765390A1 Alpha-lactalbumin gene constructs |
| 04/02/1997 | EP0765389A1 Novel cell systems having specific interaction of peptide binding pairs |
| 04/02/1997 | EP0765388A1 CRYSTAL STRUCTURE AND MUTANTS OF INTERLEUKIN-1BETA(b) CONVERTING ENZYME |
| 04/02/1997 | EP0765387A1 Method for increasing transduction of cells by adeno-associated virus vectors |
| 04/02/1997 | EP0765344A1 Inhibition of human xenogenic or allogenic antibodies to reduce xenograft or allograft rejection in human recipients |
| 04/02/1997 | EP0765343A1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6 |
| 04/02/1997 | EP0765342A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors |
| 04/02/1997 | EP0765337A1 The production of hemoglobin having a delta-like globin |
| 04/02/1997 | EP0765335A1 Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials |
| 04/02/1997 | EP0765172A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin |
| 04/02/1997 | EP0765170A1 Composition for inducing a mucosal immune response |
| 04/02/1997 | EP0765169A1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |